T he prevalence of antimicrobial drug resistance in Gram-negative bacteria continues to increase worldwide, which complicates the clinical management of infections caused by these organisms (1) . These infections include enteric as well as extraintestinal infections such as urinary tract infections (UTI), sepsis, and meningitis (2, 3) . Escherichia coli is a Gram-negative bacillus that is capable of causing urinary tract infections (UTI) and meningitis, but it is also a normal constituent of the gut microbiota of mammals (2, 4) .
E. coli isolates can be classified into pathomorphs based on the type of disease caused (2, 5) . Johnson et al. termed E. coli strains isolated from extraintestinal sites as extraintestinal pathogenic E. coli (ExPEC) based on a distinct set of virulence genes (6) . ExPEC can be further subdivided into pathomorphs that include those that cause urinary tract infection (uropathogenic E. coli [UPEC] ) and those that cause neonatal meningitis, also known as neonatal meningitis-causing E. coli [NMEC] (2, 5, (7) (8) (9) . This is an area of active research, but currently there are no virulence factors that unequivocally distinguish these groups of ExPEC.
It is thought that the E. coli strains that cause extraintestinal infections first colonize the gut (2) . From the gut the E. coli organisms are then able to spread to the urinary tract and bloodstream (2) . Animal models of E. coli meningitis have shown that once the E. coli organisms reach a high enough concentration in the bloodstream, they are able to cross the blood-brain barrier and cause meningitis (10, 11) . The severity of meningitis has been correlated with the concentration of bacteria in the bloodstream (2) . E. coli is the leading cause of UTI and second leading cause of neonatal meningitis in developed countries (2, 12) . Although it is not as common, E. coli also causes meningitis in adults (12, 13) .
Isolates of E. coli that have caused neonatal meningitis in developed countries have been extensively studied (10, (14) (15) (16) (17) (18) (19) . These studies have found that some serotypes and sequence types predominate among the E. coli strains that cause meningitis. However, these same serotypes and sequence types are found in E. coli strains isolated from other sources such as urinary tract infections, poultry, and healthy human digestive tracts (15, 16, 20) . Serotypes of E. coli that have been isolated from cases of meningitis include O18:K1, O45:K1, O1:K1, and O83:K1 (14, 19, 21, 22) . The sequence types isolated from cases of meningitis include ST95, ST62, ST131, and ST69 (14, 19, 20, (22) (23) (24) . When combinations of typing methods and more discriminant typing methods are used, isolates that have caused meningitis can be separated from isolates from other sources (15, 16) . However, most studies examined a limited number of collections of E. coli strains available for study obtained from different geographic sites and time periods, and, hence, it is unclear how significant these differences are.
There are recent reports of meningitis caused by E. coli strains that are resistant to third-generation cephalosporins and produce extended-spectrum beta-lactamases (ESBL) (23, 25) . The spread of E. coli strains that are resistant to broader-spectrum cephalosporin antibiotics is problematic because these antibiotics are recommended for the treatment of meningitis caused by E. coli (11, 12) . We sought to characterize E. coli strains isolated from UTI and meningitis patients by both multilocus sequencing typing (MLST) and the presence of ESBL genes in order to better understand the spread and distribution of drug resistance in E. coli strains that cause extraintestinal infections.
MATERIALS AND METHODS
Isolate collection. The isolates characterized in this study were originally collected as part of three separate studies of meningitis and communityacquired UTI that occurred in Salvador, Brazil (26, 27) . Due to sample loss, only a subset of the UTI isolates were characterized. All E. coli isolates from the meningitis collection were included in the current study.
As part of active hospital-based surveillance, E. coli isolates from cases of meningitis that occurred between 1996 and 2011 in Salvador were consecutively collected. The study was based at Courto Maia Hospital, which serves as the infectious disease referral hospital and reference laboratory. This laboratory is part of the public health system, and all cases of meningitis that occur in the region are required to be reported to this laboratory. As part of an ongoing study of the etiology of meningitis, limited epidemiologic information is recorded, and bacterial isolates are collected from this reference laboratory and then biobanked at the Gonçalo Moniz Research Center. The methodology and results of this study were previously published (27) .
E. coli isolates from community-acquired UTI were collected as part of two separate studies, Antimicrobial susceptibility testing. The susceptibilities of the E. coli isolates from cases of meningitis were determined with MicroScan BP38 panels (Siemens). ATCC 27853 and ATCC 25922 strains were used as reference strains for all tests.
According to the manufacturers' published breakpoints, isolates were classified as susceptible, intermediate, or resistant to each drug. Where indicated, isolates were classified as either susceptible or nonsusceptible. The nonsusceptible isolates contained all those with either the intermediate or resistant phenotype.
DNA extraction, beta-lactamase detection, and sequencing. DNA was extracted with a Promega Wizard genomic DNA kit according to the manufacturer's recommendations.
Meningitis isolates were screened for the presence of bla TEM , bla SHV , bla OXA , and bla CTX-M gene sequences with multiplex PCR protocols previously published by Dallenne et al. (28) . UTI isolates were screened for only bla TEM , bla SHV , and bla OXA . The primer sets used were Multiplex I TEM, SHV, and OXA-1-like and Multiplex II CTX-M group 1, group 2, and group 9 (28). All reactions and gel electrophoresis were performed according to previously published protocols (28) . For each reaction, DNA known to contain the relevant gene sequence was used as a positive control, and water was used as a negative control.
The PCR products that tested positive for a beta-lactamase were submitted for sequencing to the University of California, Berkeley, DNA Sequencing Facility. The resulting sequences were then submitted to BLASTN for identification (29) .
Multilocus sequence typing and sequence analysis. Multilocus sequence typing (MLST) was performed according to previously published protocols (20) . The sequences were submitted to the online MLST database at http://mlst.ucc.ie/mlst/dbs/Ecoli for sequence type (ST) identification.
All sequencing was done at the University of California, Berkeley, DNA Sequencing Facility. The resulting sequences were cleaned, assembled, and analyzed with Geneious 5.6. Data analysis. All data analyses and graphs were generated with STATA 10. P values were calculated with Fisher's exact test.
RESULTS
Characterization of E. coli causing meningitis. Thirty-six E. coli isolates from cases of meningitis were collected from patients in Salvador, Brazil, from 1996 to 2010. Figure 1 displays the year of isolation and sequence type of each of these isolates. The ages of the patients who had meningitis were known for 21 isolates. Thirteen (62%) of these isolates were from children Ͻ2 years of age. Three novel sequence types (ST3701, ST3702, and ST3703) were identified among these isolates. All of the isolates with novel sequence types were isolated from cases of meningitis in children who were Ͻ2 years old.
Among the meningitis isolates, 19% were resistant to ceftazidime and cefotaxime, 17% were resistant to aztreonam, and 14% were resistant to ciprofloxacin (Table 1 ). All isolates that were resistant to third-generation cephalosporins were found to have caused meningitis after 2002 (Fig. 1) . We did not find resistance to carbapenems, cefotetan, or tigecycline.
Eighty-six percent of isolates carried bla TEM , 13% carried bla SHV , and none carried bla OXA . Thirty-six isolates tested positive for bla CTX-M . All isolates that were resistant to third-generation cephalosporins carried a bla CTX-M -type gene. Five percent of isolates tested positive for bla CTX-M group 1, 3% for bla CTX-M group 9, and 28% for bla CTX-M group 2. Of the 13 isolates that tested positive for CTX-M, 10 yielded interpretable sequences. bla CTX-M Ϫ2 was identified in isolates ST652, ST62, ST405, ST127, ST167, ST359, and ST362. bla CTX-M-15 was found in one ST998 isolate. bla CTX-M-14 was found in one ST127 isolate (Fig. 1) .
Comparison of E. coli isolates that caused UTI and meningitis. The E. coli strains isolated from cases of meningitis had a significantly (P Ͻ 0.001) higher frequency of resistance to thirdgeneration cephalosporins than the E. coli strains that were isolated from UTI. The study of the 544 cases of UTI in Salvador that took place in [2001] [2002] found that Ͻ1% of isolates were nonsus- ceptible (intermediate or resistant phenotypes) to third-generation cephalosporins (26) . The study of the 411 cases of community-acquired UTI that took place between 2008 and 2009 found that all isolates were susceptible to third-generation cephalosporins. The current study of the 36 E. coli isolates from cases of meningitis found that 22% were nonsusceptible to third-generation cephalosporins and that 19% were resistant to third-generation cephalosporins.
We compared the E. coli strains that caused both UTI and meningitis by comparing the sequence types of isolates with identical drug-resistant phenotypes. The isolates were classified as susceptible or nonsusceptible to eight classes of antimicrobial drugs because different antimicrobial susceptibility testing methods, drugs, and breakpoints were used to characterize each collection of E. coli isolates. Only the classes of drugs that all isolates were tested with were included in this analysis. These classes were tetracyclines (TET), aminoglycosides (AMI), trimethoprim-sulfamethoxazole (TSX), penicillins (PEN), first-generation cephalosporins (CEPH1), third generation cephalosporins (CEPH3), fluoroquinolones (FLR), and nitrofurantoin (NIT). Each drug resistance phenotype was named after the classes of drugs for which the isolates were nonsusceptible.
The drug resistance phenotypes found in both the UTI and meningitis collections were Table 2 ). The available UTI isolates with these phenotypes were submitted for multilocus sequence typing and screened for the bla TEM , bla SHV , and bla OXA gene sequences. From these isolates, 10 sequence types were identified in both the meningitis and UTI collections. These sequence types were ST10, ST62, ST69, ST93, ST127, ST131, ST167, ST405, ST998, and ST2609. Of these common sequence types, three types (ST10, ST62, and ST69) had the same drug resistance phenotypes in both the men- 
DISCUSSION
To better understand the spread of drug-resistant E. coli strains, we compared MLST and presence of bla TEM and bla SHV beta-lactamase genes from E. coli strains isolated from UTI and meningitis cases. We strain typed the E. coli by an MLST protocol which is commonly used to characterize drug-resistant E. coli isolates (20, 30) . We identified a number of internationally distributed sequence types that are frequently drug resistant. These sequence types have also previously been isolated from food products and include the ST10 complex, ST69, ST117, ST131, and ST405 (30) . ST69, previously labeled CgA, was first reported from UTI patients in Berkeley, California, USA, and has also been reported from UTI patients in Rio de Janeiro, Brazil (31, 32) . ST62 has previously been associated with K1 E. coli, a serotype that frequently causes neonatal meningitis (20) . Our findings further highlight the worldwide distribution of these lineages and the fact that they are capable of causing meningitis.
The results of antimicrobial susceptibility testing of the E. coli strains that caused meningitis showed that 19% were resistant to third-generation cephalosporins. These drugs are currently recommended for the treatment of meningitis suspected to be caused by Gram-negative organisms (12) . In this study, we also identified extended-spectrum beta-lactamase genes in all meningitis isolates that were resistant to third-generation cephalosporins. In addition to the presence of bla TEM and bla SHV genes, this study identified bla CTX-M-2 , bla CTX-M-15 , and bla CTX-M-14 genes among the E. coli strains that caused meningitis. Cases of meningitis caused by ESBL-producing E. coli strains have been also been reported from Turkey, France, Algeria, Thailand, Germany, and Brazil (23, 33) .
The E. coli strains that caused meningitis were more resistant to third-generation cephalosporins than those that caused community-acquired UTI. While the numbers of E. coli strains that caused meningitis are small (n ϭ 36), this difference was still statistically significant. Unfortunately, the UTI isolates that were nonsusceptible to third-generation cephalosporins were lost, and we were unable to investigate these isolates further.
The results of this study support the findings of previous studies comparing E. coli strains from cases of meningitis and E. coli strains isolated from other sources (14, 15, 21) . These studies showed that the same sequence types are frequently found in E. coli strains that are isolated from meningitis and other sources, and once further typing schemes are applied, differences can be found. In our study, these overlapping sequence types included the most common E. coli sequence types in the UTI collection. When the drug resistance profiles and beta-lactamase genotypes were compared, many of the E. coli strains from the meningitis cases could be further differentiated from those that caused UTI. The meningitis-causing E. coli strains may express additional factors that render them more invasive.
